Self-managed titration with insulin Glargine 300 U/mL can achieve similar efficacy to physician-led titration regardless of prior insulin status in T2 DM-Results from TAKE CONTROL

dc.contributor.author	Delgado Álvarez, Elías
dc.contributor.author	Harreiter, Juergen
dc.contributor.author	Bonnemaire, Mireille
dc.contributor.author	Dauchy, Arnaud
dc.contributor.author	Donicova, Viera
dc.contributor.author	Kvapil, Milan
dc.contributor.author	Tentolouris, Nikolaos
dc.contributor.author	Popescu, Luiza
dc.contributor.author	Russel-Jones, David
dc.date.accessioned	2019-03-05T13:08:23Z
dc.date.available	2019-03-05T13:08:23Z
dc.date.issued	2018
dc.identifier.issn	0043-5325
dc.identifier.issn	1613-7671
dc.identifier.uri	http://hdl.handle.net/10651/50734
dc.description	Reunión anual de la Sociedad Austriaca de Diabetes. Las muchas caras de la prevención de la diabetes - Diagnóstico - Terapia - Tecnología (2018, Salzburgo, Austria)
dc.format.extent	p. 366-367
dc.language.iso	eng
dc.relation.ispartof	Wiener Klinische Wochenschrift. The Central European Journal of Medicine, 30(6)
dc.rights	© Springer-Verlag GmbH Austria, part of Springer Nature 2018
dc.source	WOS:000448509500048
dc.title	Self-managed titration with insulin Glargine 300 U/mL can achieve similar efficacy to physician-led titration regardless of prior insulin status in T2 DM-Results from TAKE CONTROL
dc.type	conference output	spa

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.